| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $190.8M | +6.0% | +25.5% |
| Cost of Revenue | $62.6M | +7.6% | +36.4% |
| Gross Profit | $128.2M | +5.2% | +20.8% |
| R&D Expense | $44.1M | +6.8% | +34.1% |
| SG&A Expense | $33.1M | -10.1% | +6.1% |
| Operating Income | -$37.5M | +3.1% | -15.3% |
| Pre-tax Income | -$34.1M | +1.8% | -25.2% |
| Income Tax | $1.7M | +123.7% | +95.1% |
| Net Income | -$36.0M | -29.0% | -29.0% |
| EPS (Basic) | -$0.33 | -26.9% | -22.2% |
| EPS (Diluted) | -$0.33 | -26.9% | -22.2% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $97.8M | +20.8% | +59.5% |
| Accounts Receivable | $90.2M | +2.2% | -0.1% |
| Current Assets | $502.0M | +3.6% | -18.1% |
| Total Assets | $1.04B | +1.8% | +23.7% |
| Current Liabilities | $369.4M | +4.4% | +19.8% |
| Total Liabilities | $438.9M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $52.1M | — | — |
| Capital Expenditures | $4.8M | — | — |
| Investing Cash Flow | -$43.4M | — | — |
| Financing Cash Flow | $9.2M | — | — |
| Free Cash Flow | $47.3M | — | — |
| +14.2% |
| Stockholders' Equity | $602.0M | +0.5% | +31.4% |